Determining targets for antiretroviral drug concentrations: a causal framework illustrated with pediatric efavirenz data from the CHAPAS-3 trial

Míreanna comhchosúla

• The impact of genetic polymorphisms on the pharmacokinetics of efavirenz in African children
  de réir: Bienczak, A, et al.
  Foilsithe / Cruthaithe: (2016)
• Plasma efavirenz exposure, sex, and age predict virological response in HIV-infected African children.
  de réir: Bienczak, A, et al.
  Foilsithe / Cruthaithe: (2016)
• Evaluation of an immunoassay for determination of plasma efavirenz concentrations in resource‐limited settings
  de réir: Alemseged Abdissa, et al.
  Foilsithe / Cruthaithe: (2014-01-01)
• Pharmacokinetics of antiretroviral drugs in infancy
  de réir: Helen McIlleron, et al.
  Foilsithe / Cruthaithe: (2009-12-01)
• Determinants of virological outcome and adverse events in African children treated with paediatric nevirapine fixed-dose-combination tablets
  de réir: Bienczak, A, et al.
  Foilsithe / Cruthaithe: (2017)